Incyte
INCY
#970
Rank
A$35.41 B
Marketcap
A$174.70
Share price
2.20%
Change (1 day)
40.55%
Change (1 year)

Market capitalization of Incyte (INCY)

Market cap: A$35.41 Billion

As of September 2026 Incyte has a market cap of A$35.41 Billion. This makes Incyte the world's 970th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Incyte from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$35.41 B20.68%
2025A$29.34 B36.85%
2024A$21.44 B3.82%
2023A$20.65 B-21.34%
2022A$26.25 B17.42%
2021A$22.36 B-9.72%
2020A$24.77 B-8.12%
2019A$26.96 B40.05%
2018A$19.25 B-24.8%
2017A$25.60 B-2.3%
2016A$26.20 B-5.69%
2015A$27.78 B82.03%
2014A$15.26 B65%
2013A$9.25 B333.68%
2012A$2.13 B15.37%
2011A$1.84 B-8%
2010A$2.00 B66.69%
2009A$1.20 B130.98%
2008A$0.52 B-46.28%
2007A$0.97 B56.2%
2006A$0.62 B1.97%
2005A$0.61 B-43.08%
2004A$1.07 B60.55%
2003A$0.66 B22.78%
2002A$0.54 B-78.61%
2001A$2.54 B-13.01%
2000A$2.92 B10.8%
1999A$2.63 B55.27%
1998A$1.69 B2.26%
1997A$1.66 B145.3%
1996A$0.67 B

End of Day market cap according to different sources

On Sep 15th, 2026 the market cap of Incyte was reported to be:

A$34.64 Billion
by Nasdaq info icon info icon
A$34.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$371.25 B 948.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$220.20 B 521.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.427 T 3,931.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$286.43 B 708.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$7.69 B-78.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A$1.17 B-96.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A$1.68 B-95.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A$0.73 B-97.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$1.22 B-96.55%๐Ÿ‡บ๐Ÿ‡ธ USA